160 results on '"Lima, Keli"'
Search Results
2. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia
3. Cyclopenta[b]indoles as novel antimicrotubule agents with antileukemia activity
4. Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents
5. NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma
6. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells
7. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells
8. Transcriptome Profiling Reveals Distinct Alterations in B-Cell Signature and Dysregulation of Peripheral B-Cell Subsets in Sickle Cell Anemia Patients
9. NT157 as an Anticancer Drug Candidate That Targets Kinase- and Phosphatase-Mediated Signaling
10. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells
11. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells
12. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
13. Exploring redox vulnerabilities in JAK2V617F-positive cellular models
14. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia
15. AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis
16. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
17. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia
18. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours
19. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia
20. Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs
21. PB1826: CELLULAR AND MOLECULAR CHARACTERIZATION OF THE ANTINEOPLASTIC EFFECTS OF CEPHALOCHROMIN IN MODELS OF ACUTE MYELOID LEUKEMIA
22. P347: PHARMACOLOGICAL EZRIN INHIBITION REDUCES GROWTH, ADHESION, MIGRATION AND REGULATE GENE RELATED TO APOPTOSIS AND CELL CYCLE IN ACUTE LYMPHOBLASTIC LEUKAEMIA
23. The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer Cells
24. 2-Methoxyestradiol-3,17-O,O-bis-sulfamate (STX140) Inhibits Proliferation and Invasion via Senescence Pathway Induction in Human BRAFi-Resistant Melanoma Cells
25. Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia.
26. Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
27. Differential profile of PIP4K2A expression in hematological malignancies
28. Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms
29. Targeting PIP4K2 Lipid Kinases through Thz-P1-2 Reveals Vulnerabilities Related to Mitochondrial Homeostasis and Autophagy in Acute Leukemia
30. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
31. 2-Methoxyestradiol-3,17- O , O -bis-sulfamate (STX140) Inhibits Proliferation and Invasion via Senescence Pathway Induction in Human BRAFi-Resistant Melanoma Cells.
32. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
33. Effect of FKBP12-Derived Intracellular Peptides on Rapamycin-Induced FKBP–FRB Interaction and Autophagy
34. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients
35. Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients
36. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells
37. Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms
38. Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cells
39. Targeting glioma cells by antineoplastic activity of reversine
40. Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cells
41. Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells
42. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
43. Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms.
44. The Ginkgo biloba Extract, EGb 761, Fails to Reduce Brain Infarct Size in Rats After Transient, Middle Cerebral Artery Occlusion in Conditions of Unprevented, Ischemia-induced Fever
45. Permanent, 3-stage, 4-vessel occlusion as a model of chronic and progressive brain hypoperfusion in rats: a neurohistological and behavioral analysis
46. Effect of tacrolimus (FK506) on ischemia-induced brain damage and memory dysfunction in rats
47. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours
48. MAD1L1 (mitotic arrest deficient 1 like 1)
49. PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase, type II, alpha)
50. T Cell Repertoire Diversity of Sickle Cell Anemia Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation and Conventional Treatments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.